Search

Search Constraints

You searched for: Author/Creator Ezekowitz, Justin

Search Results

1. Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial. (9th December 2019)

3. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). (4th June 2020)

4. Differentiating heart failure phenotypes using sex‐specific transcriptomic and proteomic biomarker panels. (4th March 2017)

5. Effects of age, gender, and risk‐factors for heart failure on native myocardial T1 and extracellular volume fraction using the SASHA sequence at 1.5T. Issue 5 (13th June 2018)

6. Effects of age, gender, and risk‐factors for heart failure on native myocardial T1 and extracellular volume fraction using the SASHA sequence at 1.5T. Issue 5 (22nd October 2018)

7. Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial. (20th July 2022)

9. Left atrial remodelling, mid-regional pro-atrial natriuretic peptide, and prognosis across a range of ejection fractions in heart failure. (1st May 2020)

10. Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials. (27th January 2016)